摘要
药物性肝损伤(DILI)的重要性已越来越多地引起政府医药主管部门、制药公司、临床工作者以及普通公众的重视。了解我国DILI的发生率、分布、常见诱发药物等流行病学特征,有助于DILI的预防、临床诊断和治疗,也有助于政府完善有关法规,降低药物不良反应的发生。现就我国DILI的流行病学现状作一阐述。
Drug-induced liver injury（DILI） has been taken more and more seriously by governmental authorities,pharmaceutical companies,clinical physicians,and the general public. An understanding of the incidence,and distribution of DILI and related drugs is helpful for the prevention,clinical diagnosis,and treatment of DILI and may also help the government to perfect related laws and regulations and reduce the incidence of adverse drug reactions. This article reviews the epidemiology of DILI in China.
作者
沈弢
黄昕
王誉雅
庄辉
SHEN Tao;HUANG Xin;WANG Yuya(School of Basic Medical Sciences,Peking University Health Science Center,Beijing 100191,China)
出处
《临床肝胆病杂志》
CAS
北大核心
2018年第6期1152-1155,共4页
Journal of Clinical Hepatology
关键词
药物性肝损伤
中草药
抗结核药
流行病学
drug - induced liver diseases
drugs
Chinese herbal
antitubercular agents
epidemiology
